GGrantIndex
← Leaderboards

Gary Steven Firestein

University Of California San Diego

$129,601,524
Attributed
$153,888,988
Total exposure
33
Grants
24
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $15.8M · FY200525
$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$167,842,844 · 34

By mechanism

UL1$135,940,087 · 11
R01$17,895,225 · 8
U01$5,036,160 · 1
T32$2,835,870 · 2
KL2$1,754,405 · 2
TL1$1,745,050 · 2

Top collaborators

Most similar at University Of California San Diego

Same institution · by research overlap

Others in their field

Top investigators on “Rheumatoid Arthritis

Research focus

Rheumatoid ArthritisPathway InteractionsFibroblastsInflammationCytokineResponseSynovial MembraneBaseProgramsPlayMediatingArthritisPathogenesisClinical ResearchCaliforniaGene ExpressionUniversitiesResearch InstituteTranslational ResearchTissuesTrainingResourcesClinical TrialsSynovitis

Grant awards (129)

Rheumatic Diseases Research Training Grant$279,925
T32 · FY2025 · AR
UC San Diego Clinical and Translational Research Institute$9,228,093
UL1 · FY2024 · TR · contact PI
Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH): A randomized controlled trial of methotrexate versus placebo in the treatment of chronic arthritis after chikungunya infection$1,546,361
U01 · FY2024 · AR
Identification of key regulators in rheumatoid arthritis$555,051
R01 · FY2024 · AR
Rheumatic Diseases Research Training Grant$375,968
T32 · FY2024 · AR
UC San Diego Clinical and Translational Research Institute$216,899
UL1 · FY2024 · TR · contact PI
Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH): A randomized controlled trial of methotrexate versus placebo in the treatment of chronic arthritis after chikungunya infection$148,419
U01 · FY2024 · AR
UC San Diego Clinical and Translational Research Institute$9,228,093
UL1 · FY2023 · TR · contact PI
Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH): A randomized controlled trial of methotrexate versus placebo in the treatment of chronic arthritis after chikungunya infection$1,492,743
U01 · FY2023 · AR
Identification of key regulators in rheumatoid arthritis$585,428
R01 · FY2023 · AR
Joint-location specific pathogenic pathways in rheumatoid arthritis$347,600
R01 · FY2023 · AR · contact PI
Cutting Edge Pain Research in the Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH) Trial$259,670
U01 · FY2023 · AR
UC San Diego Clinical and Translational Research Institute$213,818
UL1 · FY2023 · TR · contact PI
UC San Diego Clinical and Translational Research Institute$9,228,093
UL1 · FY2022 · TR · contact PI
Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH): A randomized controlled trial of methotrexate versus placebo in the treatment of chronic arthritis after chikungunya infection$1,588,967
U01 · FY2022 · AR
Identification of key regulators in rheumatoid arthritis$590,584
R01 · FY2022 · AR
Joint-location specific pathogenic pathways in rheumatoid arthritis$344,124
R01 · FY2022 · AR · contact PI
Joint Bioinformatics and Computational Core of the MARC$163,076
P30 · FY2022 · AR · contact PI
UC San Diego Clinical and Translational Research Institute$9,048,799
UL1 · FY2021 · TR · contact PI
Identification of key regulators in rheumatoid arthritis$578,386
R01 · FY2021 · AR
Pathogenic role of ILC2 in rheumatoid arthritis$168,586
R21 · FY2021 · AR · contact PI
Joint Bioinformatics and Computational Core of the MARC$164,432
P30 · FY2021 · AR · contact PI
UC San Diego Clinical and Translational Research Institute$145,499
UL1 · FY2021 · TR · contact PI
UC San Diego Clinical and Translational Research Institute$9,039,702
UL1 · FY2020 · TR · contact PI
Identification of key regulators in rheumatoid arthritis$605,000
R01 · FY2020 · AR
Joint-location specific pathogenic pathways in rheumatoid arthritis$346,500
R01 · FY2020 · AR · contact PI
Pathogenic role of ILC2 in rheumatoid arthritis$207,955
R21 · FY2020 · AR · contact PI
Joint Bioinformatics and Computational Core of the MARC$164,980
P30 · FY2020 · AR · contact PI
UC San Diego Clinical and Translational Research Institute$8,383,456
UL1 · FY2019 · TR · contact PI
Joint-location specific pathogenic pathways in rheumatoid arthritis$346,500
R01 · FY2019 · AR · contact PI
Joint Bioinformatics and Computational Core of the MARC$166,499
P30 · FY2019 · AR · contact PI
UC San Diego Clinical and Translational Research Institute$8,383,456
UL1 · FY2018 · TR · contact PI
UC San Diego Clinical and Translational Research Institute$477,056
UL1 · FY2018 · TR · contact PI
Joint-location specific pathogenic pathways in rheumatoid arthritis$345,400
R01 · FY2018 · AR · contact PI
High resolution DNA methylation signature in rheumatoid arthritis$341,000
R01 · FY2018 · AR · contact PI
Joint Bioinformatics and Computational Core of the MARC$167,134
P30 · FY2018 · AR · contact PI
UC San Diego Clinical and Translational Research Institute$8,383,455
UL1 · FY2017 · TR · contact PI
High resolution DNA methylation signature in rheumatoid arthritis$341,000
R01 · FY2017 · AR · contact PI
Identifying synergistic therapeutic targets in RA using systems biology$170,500
R21 · FY2017 · AR
UC San Diego Clinical and Translational Research Institute$8,383,456
UL1 · FY2016 · TR · contact PI
Regulation of p38 and inflammation by MAPK kinases$387,500
R01 · FY2016 · AI · contact PI
High resolution DNA methylation signature in rheumatoid arthritis$341,000
R01 · FY2016 · AR · contact PI
Identifying synergistic therapeutic targets in RA using systems biology$204,600
R21 · FY2016 · AR
UC San Diego Clinical and Translational Research Institute$7,963,176
UL1 · FY2015 · TR · contact PI
San Diego Clinical and Translational Research Institute$1,356,068
UL1 · FY2015 · TR · contact PI
Regulation of p38 and inflammation by MAPK kinases$387,500
R01 · FY2015 · AI · contact PI
Regulation of the type I interferon response by IRFs in inflammatory arthritis$348,750
R01 · FY2015 · AR · contact PI
High resolution DNA methylation signature in rheumatoid arthritis$341,000
R01 · FY2015 · AR · contact PI
San Diego Clinical and Translational Research Institute$5,272,159
UL1 · FY2014 · TR · contact PI
Regulation of p38 and inflammation by MAPK kinases$387,500
R01 · FY2014 · AI · contact PI
High resolution DNA methylation signature in rheumatoid arthritis$341,000
R01 · FY2014 · AR · contact PI
San Diego Clinical and Translational Research Institute$253,427
KL2 · FY2014 · TR · contact PI
San Diego Clinical and Translational Research Institute$85,444
UL1 · FY2014 · TR · contact PI
San Diego Clinical and Translational Research Institute$986
TL1 · FY2014 · TR · contact PI
San Diego Clinical and Translational Research Institute$6,027,635
UL1 · FY2013 · TR · contact PI
San Diego Clinical and Translational Research Institute$461,820
KL2 · FY2013 · TR · contact PI
San Diego Clinical and Translational Research Institute$429,300
TL1 · FY2013 · TR · contact PI
Regulation of p38 and inflammation by MAPK kinases$364,250
R01 · FY2013 · AI · contact PI
San Diego Clinical and Translational Research Institute$6,968,018
UL1 · FY2012 · TR · contact PI
San Diego Clinical and Translational Research Institute$429,300
TL1 · FY2012 · TR · contact PI
San Diego Clinical and Translational Research Institute$424,179
KL2 · FY2012 · TR · contact PI
Regulation of p38 and inflammation by MAPK kinases$387,188
R01 · FY2012 · AI · contact PI
c-Jun N-terminal kinase and joint destruction in RA$290,737
R01 · FY2012 · AR · contact PI
San Diego Clinical and Translational Research Institute$6,551,778
UL1 · FY2011 · RR · contact PI
SAN DIEGO CLINICAL AND TRANSLATIONAL RESEARCH INSTITUTE$2,704,012
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$2,366,002
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$1,351,970
UL1 · FY2011 · RR · contact PI
San Diego Clinical and Translational Research Institute$461,820
KL2 · FY2011 · RR · contact PI
San Diego Clinical and Translational Research Institute$424,166
TL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$356,777
UL1 · FY2011 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$356,777
UL1 · FY2011 · RR · contact PI
Innate immunity and the IKKi complex in Rheumatoid Arthritis (RA) synovium$334,234
R01 · FY2011 · AI · contact PI
San Diego Clinical and Translational Research Institute$292,099
UL1 · FY2011 · RR · contact PI
San Diego Clinical and Translational Research Institute$291,661
UL1 · FY2011 · RR · contact PI
c-Jun N-terminal kinase and joint destruction in RA$290,737
R01 · FY2011 · AR · contact PI
San Diego Clinical and Translational Research Institute$6,818,318
UL1 · FY2010 · RR · contact PI
SAN DIEGO CLINICAL AND TRANSLATIONAL RESEARCH INSTITUTE$4,636,456
UL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$1,500,030
UL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$681,832
UL1 · FY2010 · RR · contact PI
San Diego Clinical and Translational Research Institute$461,298
TL1 · FY2010 · RR · contact PI
Innate immunity and the IKKi complex in Rheumatoid Arthritis (RA) synovium$337,610
R01 · FY2010 · AI · contact PI
Regulation of p38 and inflammation by MAPK kinases$327,820
R01 · FY2010 · AI · contact PI
c-Jun N-terminal kinase and joint destruction in RA$302,851
R01 · FY2010 · AR · contact PI
Training grant in Rheumatic Diseases$236,234
T32 · FY2010 · AR · contact PI
Regulation of p38 and inflammation by MAPK kinases$165,554
R01 · FY2010 · AI · contact PI
San Diego Clinical and Translational Research Institute$153,159
KL2 · FY2010 · RR · contact PI
Innate immunity and the IKKi complex in Rheumatoid Arthritis (RA) synovium$341,020
R01 · FY2009 · AI · contact PI
Regulation of p38 and inflammation by MAPK kinases$331,131
R01 · FY2009 · AI · contact PI
c-Jun N-terminal kinase and joint destruction in RA$305,910
R01 · FY2009 · AR · contact PI
Training grant in Rheumatic Diseases$225,796
T32 · FY2009 · AR · contact PI
Innate immunity and the IKKi complex in Rheumatoid Arthritis (RA) synovium$341,020
R01 · FY2008 · AI · contact PI
Regulation of p38 and inflammation by MAPK kinases$331,131
R01 · FY2008 · AI · contact PI
c-Jun N-terminal kinase and joint destruction in RA$305,910
R01 · FY2008 · AR · contact PI
Training grant in Rheumatic Diseases$232,839
T32 · FY2008 · AR · contact PI
Innate immunity and the IKKi complex in Rheumatoid Arthritis (RA) synovium$347,625
R01 · FY2007 · AI · contact PI
Regulation of p38 and inflammation by MAPK kinases$336,452
R01 · FY2007 · AI · contact PI
Training grant in Rheumatic Diseases$208,140
T32 · FY2007 · AR · contact PI
Synovial dysfunction due to p53 abnormalities in RA$347,204
R01 · FY2006 · AR · contact PI
Regulation of p38 and inflammation by MAPK kinases$346,500
R01 · FY2006 · AI · contact PI
'c-Jun N-terminal kinase and joint destruction in RA'$274,683
R01 · FY2006 · AR · contact PI
Training grant in Rheumatic Diseases$240,218
T32 · FY2006 · AR · contact PI
Synovial dysfunction due to p53 abnormalities in RA$355,558
R01 · FY2005 · AR
RHEUMATIC DISEASES$242,036
T32 · FY2005 · AR
'c-Jun N-terminal kinase and joint destruction in RA'$230,090
R01 · FY2005 · AR
IKKi expression and regulation in rheumatoid arthritis$76,000
R03 · FY2005 · AI
Synovial dysfunction due to p53 abnormalities in RA$368,228
R01 · FY2004 · AR
'c-Jun N-terminal kinase and joint destruction in RA'$250,040
R01 · FY2004 · AR
RHEUMATIC DISEASES$197,680
T32 · FY2004 · AR
IKKi expression and regulation in rheumatoid arthritis$76,000
R03 · FY2004 · AI
Synovial dysfunction due to p53 abnormalities in RA$357,499
R01 · FY2003 · AR
'c-Jun N-terminal kinase and joint destruction in RA'$250,040
R01 · FY2003 · AR
RHEUMATIC DISEASES$215,555
T32 · FY2003 · AR
Synovial dysfunction due to p53 abnormalities in RA$360,087
R01 · FY2002 · AR
REGULATION OF PERIPHERAL INFLAMMATION BY THE CNS$280,693
R01 · FY2002 · AR
RHEUMATIC DISEASES$227,634
T32 · FY2002 · AR
'c-Jun N-terminal kinase and joint destruction in RA'$200,040
R01 · FY2002 · AR
CORE--RESEARCH RESOURCES$150,001
P50 · FY2002 · AR
Core--Biomarker$0
P30 · FY2002 · AR
REGULATION OF PERIPHERAL INFLAMMATION BY THE CNS$272,865
R01 · FY2001 · AR
RHEUMATIC DISEASES$153,845
T32 · FY2001 · AR
CORE--RESEARCH RESOURCES$150,001
P50 · FY2001 · AR
SYNOVIAL DYSFUNCTION DUE TO P53 ABNORMALITIES IN RA$108,128
R01 · FY2001 · AR
c-Jun N-terminal kinase and joint destruction in RA$100,000
R55 · FY2001 · AR
Core--Biomarker$0
P30 · FY2001 · AR
SYNOVIAL DYSFUNCTION DUE TO P53 ABNORMALITIES IN RA$326,651
R01 · FY2000 · AR
REGULATION OF PERIPHERAL INFLAMMATION BY THE CNS$264,916
R01 · FY2000 · AR
CORE--RESEARCH RESOURCES$196,912
P50 · FY2000 · AR
CORE--RESEARCH RESOURCES$196,912
P50 · FY2000 · AR
DOMINANT NEGATIVE IKK1 GENE THERAPY IN RHEUMATOID ARTHRITIS$112,459
P60 · FY2000 · AR